The Latest Cardiac and Vascular News
SANTA CLARA, Calif., Oct. 4, 2018 /PRNewswire/ — EPIX Therapeutics, Inc., a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced achievement of the enrollment goal of the DIAMOND-AF study, a global FDA-approved IDE pivotal study to evaluate the DiamondTemp Ablation […]
MONTRÉAL, Oct. 03, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announced today that it intends to offer and sell its common […]
BOSTON–(BUSINESS WIRE)–LuxCath, LLC, a medical device company developing a novel cardiac catheter ablation technology, today announced that Terry Ransbury has been appointed its Chief Technology Officer. Mr. Ransbury is a seasoned industry veteran who brings over 30 years of experience in research and development, specializing in electrophysiology and cardiac rhythm […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced it has commenced an underwritten public offering of 2.5 million shares of its common stock pursuant to its existing shelf registration statement. In connection with this offering, […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the third quarter ended September 30, 2018 is expected to be in the range of $34.3 million to $34.7 million. Also, based on current business trends, […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc. announced today that Scott Kraus has joined the Company as its Vice President of Sales and Business Development. Scott most recently served as the Area Vice President – East for Intersect ENT, a position he has held since October of 2014. Prior to […]
TEMPE, Ariz., Oct. 3, 2018 /PRNewswire/ — Officials from BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, were joined today by Gov. Doug Ducey, Tempe Mayor Mark Mitchell and representatives of The Boyer Company to officially break ground on the new I.D.E.A. (Innovation, Discovery, Education and Arts) Tempe campus. BD Peripheral Intervention will be the first […]
DALLAS, Oct. 2, 2018 /PRNewswire/ — CardioVascular BioTherapeutics, Inc. (“CVBT” or the “Company”) is pleased to welcome Ori Ben-Yehuda, MD, FACC as our new Chief Medical Officer (CMO). “Dr. Ben-Yehuda brings leading edge skills and demonstrated drug development success to the Company. He will guide our clinical team in our current and future development […]
CAESAREA, Israel, Oct. 3, 2018 /PRNewswire/ — V-Wave Ltd. announced today that it has enrolled the first patients in its global, 500 patient pivotal study of its proprietary, minimally invasive implanted interatrial shunt device for treating patients with NHYA Class III and ambulatory Class IV symptomatic heart failure (HF). This randomized, controlled, double-blinded […]
NEW YORK and MELBOURNE, Australia, Oct. 02, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today announced that the 159-patient randomized placebo-controlled Phase 2b trial evaluating its allogeneic mesenchymal precursor cell (MPC) product candidate MPC-150-IM in the treatment of end-stage heart failure patients implanted with a left ventricular assist device (LVAD) has […]
